Montclair, NJ, United States of America

David L Miller

This inventor holds 1 USPTO granted patent. Top assignee: Hoffmann-La Roche Inc.. Active years: 1987.

IDiyas Innovation Intelligence. (2026). Inventor Profile: David L Miller. Retrieved from https://idiyas.com/inventor/david-l-miller-eqg81k3q

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 29(Granted Patents)


Company Filing History:


Years Active: 1987

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of David L. Miller

Introduction

David L. Miller is a notable inventor based in Montclair, NJ (US). He has made significant contributions to the field of biotechnology, particularly in the area of human leukocyte interferon. His work has implications for medical research and treatment.

Latest Patents

David L. Miller holds 1 patent for his invention titled "Crystalline human leukocyte interferon." This patent describes the crystallization of human leukocyte interferon, with a preferred embodiment involving the preparation of crystalline recombinant human leukocyte interferon A (IFL-rA). This innovation is crucial for advancing therapeutic applications.

Career Highlights

Miller is associated with Hoffmann-La Roche Inc., a leading company in the pharmaceutical industry. His work there has allowed him to focus on groundbreaking research and development in biotechnology.

Collaborations

Throughout his career, David L. Miller has collaborated with esteemed colleagues, including Hsiang-Fu Kung and Sidney Pestka. These partnerships have fostered innovation and contributed to the advancement of their shared field.

Conclusion

David L. Miller's contributions to biotechnology, particularly through his patent on human leukocyte interferon, highlight his role as an influential inventor. His work continues to impact medical research and treatment options.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…